Literature DB >> 18362070

Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.

Vijaya Gracias1, Zhiqin Ji, Irini Akritopoulou-Zanze, Cele Abad-Zapatero, Jeffrey R Huth, Danying Song, Philip J Hajduk, Eric F Johnson, Keith B Glaser, Patrick A Marcotte, Lori Pease, Nirupama B Soni, Kent D Stewart, Steven K Davidsen, Michael R Michaelides, Stevan W Djuric.   

Abstract

We report the discovery of the pyrimido-diazepine scaffolds as novel adenine mimics. Structure-based design led to the discovery of analogs with potent inhibitory activity against receptor tyrosine kinases, such as KDR, Flt3 and c-Kit. Compound 14 exhibited low nanomolar KDR enzymatic and cellular potencies (IC(50)=9 and 52 nM, respectively).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362070     DOI: 10.1016/j.bmcl.2008.03.021

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Inhibition of the sole type I signal peptidase of Mycobacterium tuberculosis is bactericidal under replicating and nonreplicating conditions.

Authors:  J Ollinger; T O'Malley; J Ahn; J Odingo; T Parish
Journal:  J Bacteriol       Date:  2012-03-16       Impact factor: 3.490

2.  Superelectrophilic chemistry of amino-nitriles and related substrates.

Authors:  Erum K Raja; Douglas A Klumpp
Journal:  Tetrahedron       Date:  2011-06-24       Impact factor: 2.457

3.  HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.

Authors:  François Degorce; Amy Card; Sharon Soh; Eric Trinquet; Glenn P Knapik; Bing Xie
Journal:  Curr Chem Genomics       Date:  2009-05-28

Review 4.  FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML.

Authors:  Ellen Weisberg; Rosemary Barrett; Qingsong Liu; Richard Stone; Nathanael Gray; James D Griffin
Journal:  Drug Resist Updat       Date:  2009-05-20       Impact factor: 18.500

5.  1-Eth-oxy-methyl-5-methyl-9-phenyl-6,7,8,9-tetra-hydro-1H-pyrimido[4,5-b][1,4]diazepine-2,4(3H,5H)-dione.

Authors:  Gong Li; Xiaowei Wang; Zhili Zhang; Junyi Liu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-18

6.  Kinetic barriers in the isomerization of substituted ureas: implications for computer-aided drug design.

Authors:  Johannes R Loeffler; Emanuel S R Ehmki; Julian E Fuchs; Klaus R Liedl
Journal:  J Comput Aided Mol Des       Date:  2016-06-07       Impact factor: 3.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.